Analysis published 17 May 2026

AI-generated · cited to primary sources · not investment advice

DDev Plastiks (543547) May 2025 Filing Analysis

01 · Management Credibility

Does management do what it says?

MetExport Revenue Percentage
85/100

The revenue contribution from overseas markets reached exactly 25% in Q2FY26. (1 met across 1 tracked commitment)

Bhargav Buddhadev: So, sir, in FY '26, can we expect the share of exports to come back to 25% of overall revenue? Ddev Surana: Yes, absolutely.

DDev Plastiks · Concall Transcript · May 2025 · p.9
MetCustomer Specification and Qualification Moat (PRINCIPLE)
68/100

The timeline for U.S. certifications has been slightly extended. While one product is certified, two more are now expected in the next 5-6 months, compared to the previous 3-month estimate. (1 revised, 1 met across 2 tracked commitments)

Yes. So we expect that within next 1 month, we should have these approvals in our hand... And we expect at least one approval before June 2025. It should happen in the next 2 to 3 weeks' time. And then the next 2 approvals should come another 3 months' time.

DDev Plastiks · Concall Transcript · May 2025 · p.19
In progressCapex to Revenue Ratio
60/100

Management reaffirmed that the capex plans for the current financial year remain on track with an expected investment of approximately INR 110 crores. (1 in progress across 1 tracked commitment)

we plan to invest another Rs 110 odd crores in this current fiscal year to support our continued growth and expansion initiatives.

DDev Plastiks · Concall Transcript · May 2025 · p.7

See the full cited Management analysis of DDev Plastiks

Create free account →
02 · Business Model

How durable is the business?

New Capacity Commissioning and Revenue Ramp
80/100

The company's scale moat is expanding through capacity utilization improvements (from 70% to 81%) and a dominant 50% market share in Sioplas and 33% in XLPE compounds. (5 expanding)

Total Installed Capacity ... % Utilization ... FY24 70% ... FY25 81%

DDev Plastiks · Investor PPT · May 2025 · p.23
Average Revenue per Active Molecule
67/100

The PE segment, which includes high-margin XLPE (Cross-linked Polyethylene), has expanded its revenue share and volume significantly. XLPE now accounts for 73% of production volumes, up from 69% in the previous year, driven by demand in the power and cable sectors. (1 expanding, 2 stable)

Production Volumes (in MT) & Product Wise Volume Split (%) ... XLPE ... FY24 69% ... FY25 73%

DDev Plastiks · Investor PPT · May 2025 · p.18
Capex to Revenue Ratio
60/100

The company maintained its net debt-free status while increasing net worth from INR 660 Cr to INR 835 Cr, providing a strong foundation for the planned INR 110 Cr capex in FY26. (4 stable)

Net-worth (INR cr) ... FY24 660 ... FY25 835 ... We became net debt-free in 4QFY24 and are committed to maintaining this status.

DDev Plastiks · Investor PPT · May 2025 · p.20

See the full cited Business Model analysis of DDev Plastiks

Create free account →
03 · Future Growth

Where does growth come from?

Customer Specification and Qualification Moat

The company is successfully deepening its wallet share with top clients, with the top 10 clients now contributing 39% of revenue in FY25 compared to 26% in FY20. (2 accelerating, 3 new trend across 5 signals)

Wallet Share from existing clients ... % of revenue from top 10 clients ... FY25 39%

DDev Plastiks · Investor PPT · May 2025 · p.26

See the full cited Future Growth analysis of DDev Plastiks

Create free account →
04 · Risk

What could break the thesis?

R&D and Process Chemistry Differentiation

The risk is stable; while new competition entered the market last year causing pricing adjustments, the company maintains high market shares (up to 80% in some segments) and relies on R&D moats. (2 stable)

These are the differentiator between us and any other competitor and our XLPE product... our R&D backup and understanding of the product chemistry is so strong.

DDev Plastiks · Concall Transcript · May 2025 · p.13

See the full cited Risk analysis of DDev Plastiks

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.